Takahiro Kuno: Management of VTE Across Renal Function and Hemodialysis Status
Takahiro Kuno, Visiting Researcher at The University of Tokyo Hospital, Cardiologist and PhD Candidate at Gunma University Hospital, shared a post on LinkedIn:
“A bit delayed, but I had the privilege of attending ACC.26 in New Orleans last month.
I presented our analysis from the COMMAND VTE Registry-2 examining management and outcomes of venous thromboembolism (VTE) across renal function and hemodialysis status.
A key takeaway: bleeding risk in VTE patients is not driven by eGFR alone—being on hemodialysis itself confers additional bleeding risk, beyond what renal function metrics capture.
This nuance matters when we counsel patients on anticoagulation strategy.
It was also my first time in New Orleans, and the jazz culture was a wonderful surprise.
I’d love to go back.
Grateful to all collaborators in the COMMAND VTE Registry-2 investigators group, and to my mentors for their guidance.”
Stay updated with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy